With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...

In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...

AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...

Novartis and Matchpoint Therapeutics have entered into a partnership worth $1bn to develop oral inhibitors for inflammatory ...

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by the European Commission (EC) to treat adults with relapsed or refractory multiple myeloma.

Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by the European Commission (EC) to treat adults with relapsed or refractory multiple myeloma. The drug has been authorised ...

We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education ...

Unlock the power of AI to transform pharma medical education, training, and critical insight gathering. Discover how next-gen ...

Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.